These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 320426)

  • 1. [Clinical experience with etiroxate hydrochloride in patients with primary hyperlipoproteinemia].
    Knüchel F
    Med Welt; 1977 Jan; 28(4):186-9. PubMed ID: 320426
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies of the lipid-lowering activity of etiroxate hydrochloride and dextrothyroxine (author's transl)].
    Schwartzkopff W; Russ E
    MMW Munch Med Wochenschr; 1975 May; 117(19):827-30. PubMed ID: 805950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of hyperlipoproteinemia type IIa and IIb with etiroxate-HCl. Dose-response comparison].
    Banz H; Gall FP
    Fortschr Med; 1979 Nov; 97(42):1942-1947. PubMed ID: 520990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expeimental studies in animals on a new lipid lowering compound: etiroxate hydrochloride (author's transl)].
    Beckmann R
    Arzneimittelforschung; 1979; 29(3):499-508. PubMed ID: 582735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of serum lipids by means of etiroxate (Liponorm).
    Lageder H; Irsigler K
    Atherosclerosis; 1975; 22(3):473-84. PubMed ID: 1212278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of primitive hyperlipidemias with a tetralin derivative].
    Fellin R; Fedele D; Bagnariol G; Pagnan A; Crepaldi G
    G Ital Cardiol; 1972; 2(6):863-70. PubMed ID: 4564549
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypolipaemic drugs and coronary heart disease.
    Howard AN
    J Clin Pathol Suppl (R Coll Pathol); 1975; 9():106-14. PubMed ID: 783209
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dietetic and drug therapy of hyperlipidemias and hyperlipoproteinemia].
    Huth K; Blumenthal J; Schmahl FW
    Med Klin; 1973 Aug; 68(34):1089-97. PubMed ID: 4790868
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of chenodeoxycholic acid on serum triglycerides in patients with primary hypertriglyceridemia.
    Camarri E; Fici F; Marcolongo R
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):523-6. PubMed ID: 365796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the effect of d-thyroxine in patients with increased serum lipid level].
    Steger H
    Wien Klin Wochenschr; 1968 Nov; 80(47):887-98. PubMed ID: 5717659
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia].
    Arteaga A; Foradori A; Eyzaguirre J; Lira P; Vasquez A; Soto S; Alliende ME; Guzman L
    Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of hexanicotinate of meso-inositol in patients with primary hyperlipidemia (author's transl)].
    Agusti R; Jordán C; Aste H; Tapia F
    Rev Invest Clin; 1978; 30(4):327-35. PubMed ID: 362498
    [No Abstract]   [Full Text] [Related]  

  • 13. Gemfibrozil and clofibrate in the treatment of hyperlipidaemias. A comparative trial.
    Eisalo A; Manninen V
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):44-6. PubMed ID: 798196
    [No Abstract]   [Full Text] [Related]  

  • 14. [First clinical experiences in therapy of hyperuricemia and hyperlipidemia with the clofibrate derivative MK 185].
    Wolfram G; Keller C; Kilani C; Zöllner N
    Verh Dtsch Ges Inn Med; 1973; 79():1291-3. PubMed ID: 4597609
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical testing of a combination of clofibrate and beta-pyridylcarbinol in an unusual dosis relation].
    Mann S; Maisenbacher HJ
    Z Allgemeinmed; 1975 Aug; 51(24):1066-71. PubMed ID: 1101545
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of clofibrate and bezafibrate in type IIa and type IIb hyperlipoproteinemia].
    Arntz HR; Klemens UH; Vollmar LJ; Lang PD
    Med Klin; 1978 Dec; 73(49):1731-7. PubMed ID: 723760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A double-blind cross-over trial of a new hypolipidaemic drug (author's transl)].
    Proto C; Quadri A; Ratti S; Levi GF; Prandini BD
    G Ital Cardiol; 1978; 8(7):743-51. PubMed ID: 355033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of hyperlipoproteinemias type II a and II b using dextro-thyroxine or D,L-alpha-methyl-thyroxine-ethylester].
    Schwartzkopff W
    Verh Dtsch Ges Inn Med; 1972; 78():1621-3. PubMed ID: 4353151
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cholestyramine as a cholesterol lowering preparation. A clinical evaluation].
    Bye A; Brox D
    Tidsskr Nor Laegeforen; 1976 Jun; 96(16):928-9. PubMed ID: 779134
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of increasing doses of gemfibrozil in hyperlipoproteinaemia.
    Lageder H; Irsigler K
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):71-5. PubMed ID: 798199
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.